# Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke

> **NCT05107206** · NA · TERMINATED · sponsor: **NeuroVasc Technologies** · enrollment: 12 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DEVICE:** Mechanical Thrombectomy using the Envi™-SR Thrombectomy device
- **DEVICE:** Mechanical Thrombectomy using the Solitaire or Trevo Revascularization Device

## Key facts

- **NCT ID:** NCT05107206
- **Lead sponsor:** NeuroVasc Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-06-23
- **Primary completion:** 2023-05-18
- **Final completion:** 2025-01-27
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Study was terminated due to management decision. Study was not terminated due to safety reasons.
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05107206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05107206, "Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05107206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*